Concepedia

Patricia Brown‐Augsburger

PB

Statistics

Publications

21

Citations

2K

H-Index

18

Active since

1994

Affiliations

Eli Lilly (United States)(Current)

Washington University in St. Louis

New York University

University of North Carolina at Chapel Hill

The University of Texas Medical Branch at Galveston

Patricia Brown‐Augsburger is an author at Eli Lilly (United States) specializing in molecular biology, life sciences, and pharmacy.

ORCID

Publications per year

1994–2022

21

Publications

21

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 497 citations · Full text

, , +17

Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

Charles A. Frolik, Elwood C. Black, Ricky L. Cain et al. · Bone · 2003 · 211 citations

, , +11

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 175 citations · Full text

, , +17

Identification of an Elastin Cross-linking Domain That Joins Three Peptide Chains

Patricia Brown‐Augsburger, Clarina Tisdale, Thomas J. Broekelmann et al. · Journal of Biological Chemistry · 1995 · 167 citations · Full text

, , +17

Microfibril-associated glycoprotein binds to the carboxyl-terminal domain of tropoelastin and is a substrate for transglutaminase.

Patricia Brown‐Augsburger, Thomas J. Broekelmann, Lisa Mecham et al. · Journal of Biological Chemistry · 1994 · 125 citations · Full text

, , +14

1–5 of 21